विगत शोध छात्र

• Co Supervised 8 MD Students and 6 DM Students.

जारी अनुसंधान परियोजनाएं

• Establishment of Center of Excellence in SCD
• Mission Program on Pediatric Rare Genetic Disorders

वर्तमान अनुसंधान सहयोगी

N/A

विगत अनुसंधान सहयोगी

N/A

समाचार में शोध

N/A

पुरस्कार / मान्यता / सम्मान

• Dhirendra Nath Das Best paper published award by Indian Society of hematology and blood transfusion presented at Hematocon 2015 conference at Bangalore 5th to 8th Nov 2015.
• Young Scientist Award under DST-Fast Track Scheme Aug 2012.
• Research Associate Award by Council of Scientific and Industrial Research (CSIR) March 2012.
• Best oral presentation award in International Conference of Genomic and Biomedical Research organized by Human Genetic Center, Department of Zoology, Gujarat University in Jan 2009.
• Lectureship Exam (LS-NET), conducted by Council of Scientific and Industrial Research (CSIR) and University Grant commission (UGC) in Dec 2007.
• Graduate Aptitude Test in Engineering (GATE) in Jan 2007 conducted by Indian Institute of Technology.
• Junior Research Fellowship Exam (JRF-NET), conducted by Council of Scientific and Industrial Research(CSIR) and University Grant commission (UGC) in June 2007 under UGC Scheme.
• Junior Research Fellowship Exam (JRF-NET), conducted by Council of Scientific and Industrial Research(CSIR) and University Grant commission (UGC) in Dec 2006 under CSIR Scheme.

संगठित कार्यशाला / सम्मेलन

• State Level SCD Conference Madhya Pradesh on 3 Jan 2024 jointly organized by NASCO and NHM Bhopal.
• Symposium on Sickle Cell Disease in India on 22 and 23 Feb 2023
• Conference on Holistic Management of Sickle Cell Disease on World Sickle Cell Day, 19 Jun 2022
• Webinar on “Sickle Cell Disease: Global Perspective and Indian Scenario” on World Sickle Cell Day, 19 June 2021
• Hands on Training program for pathologists and technician on “Screening and diagnosis of hemoglobinopathies”. March 2020 at ICMR-NIRTH, Jabalpur
• Hands on Training program for pathologists and technician on “Screening and diagnosis of hemoglobinopathies”. August and September 2019 at ICMR-NIRTH, Jabalpur
• Orientation Program for CMO/CMHO/BMO on Hemoglobinopathies, Diagnosis, Prevention and management. September 2018 at ICMR-NIRTH, Jabalpur
• One Day Seminar on Organization and Ethics of Biomedical Research Publications on 1st Jun 2018 at ICMR-NIRTH, Jabalpur
• One Day CME on Thalassemia on 8th May 2016 at Sri Aurobindo Medical College and Post Graduate Institute, Indore
• One Day CME on Frontiers in Management of Thalassemia at Sri Aurobindo Medical College and Post Graduate Institute, Indore on 31st August 2014 with 2 CME credits by Madhya Pradesh Medical Council
• Five-day hands-on workshop and symposium on advanced laboratory practice in Molecular and Forensic Medicine from 16th -20th 2013 at Sri Aurobindo Medical College and Post Graduate Institute, Indore

शैक्षणिक योगदान

Ph. D.: Nil

Masters dissertation: 6

Papers published: 111

अनुसंधान अनुदान

प्रकाशन

Research Publications (Last 7 Years)

• Nambison NKM, Dwivedi AD, Kumar S, Goel G, Prasad P, Singh G, Rajasubramaniam S, Kumar R. Population-based Research in AYUSH: Lessons from Study among Particularly Vulnerable Tribal Groups to Determine Burden of Sickle Cell Disorders. Journal of Applied Sciences and Clinical Practice. 2024;5(3):138-144.
• Seth T, Udupi S, Jain S, Bhatwadekar S, Menon N, Jena RK, Kumar R, Ray S, Parmar B, Goel AK, Vasava A, Dutta A, Samal P, Ballikar R, Bhat D, Dolai TK, Bhattacharyya J, Shetty D, Mistry M, Jain D. Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients. Br J Haematol. 2024 Oct 28. doi: 10.1111/bjh.19829. Epub ahead of print. PMID: 39463175. IF: 5.2
• Gupta P, Kumar R. Targeting ICAM1 to Ameliorate Vaso-Occlusion and Inflammation in Sickle Cell Disease. Eur J Haematol. 2024 Oct 1. doi: 10.1111/ejh.14313. Epub ahead of print. PMID: 39354752. IF: 2.3
• Rao E, Patel D, Saxena N, Saha KB, Kumar R. Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint. Hemoglobin. 2024;48(3):212-213. doi: 10.1080/03630269.2024.2356607. Epub 2024 Sep 27. PMID: 39329378. IF: 1.2
• Sondhiya G, Manjunathachar HV, Singh P, Kumar R. Unveiling the Burden of Scrub Typhus in Acute Febrile Illness Cases across India: A Systematic review and Meta-analysis. Indian J Med Res. 2024;159(6):601-618. doi: 10.25259/ijmr_1442_23. IF: 2.7
• Gupta P, Choudhari V, Kumar R. Exploring the genetic mechanisms: SELP gene's contribution to alleviating vaso-occlusive crisis in sickle cell disease. Gene. 2024;928:148805. doi: 10.1016/j.gene.2024.148805. Epub ahead of print. PMID: 39079562. IF: 2.6
• Gupta P, Kumar R. Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease. Nitric Oxide. 2024. S1089-8603(24)00017-X. doi: 10.1016/j.niox.2024.01.008. Epub ahead of print. PMID: 38316197. Impact Factor: 3.9
• Patel D, Kumar R. Community health workers in India should be trained to offer genetic counseling for rare diseases. Nat Med. 2024. doi 10.1038/s41591-023-02748-z. Epub ahead of print. PMID: 38200260. Impact Factor: 82.9
• Rao E, Chandraker SK, Singh MM, Kumar R. Global distribution of β-thalassemia mutations: An Update. Gene. 2023 Nov 23:148022. doi: 10.1016/j.gene.2023.148022. Epub ahead of print. PMID: 38007159.
• Gupta P, Singh P, Das A, Kumar R. Determinants of tuberculosis: an example of high tuberculosis burden in the Saharia tribe. Front Public Health. 2023 Oct 18;11:1226980. doi: 10.3389/fpubh.2023.1226980. PMID: 37920577; PMCID: PMC10619692. Impact Factor: 5.2
• Singh MPSS, Kumar R, Patel P, Uikey R, Mun A, Shanmugam R. Hemoglobinopathies Among Patients Referred to Single Centre in Central India: An Observational Study. Ind J Clin Biochem. 2023. https://doi.org/10.1007/s12291-023-01151-2. Impact Factor: 2.1
• Narayan A, Shrivastava V, Kumar R. Excerpt of Symposium on Sickle Cell Disease in India. Current Science. 2023;125(7):715-7. Impact Factor: 1.169
• Gupta P, Kumar R. GTP cyclohydroxylase1 (GCH1): Role in neurodegenerative diseases. Gene. 2023;888:147749. doi: 10.1016/j.gene.2023.147749. PMID: 37652170. Impact Factor: 3.5
• Kumar R, Chandraker SK, Das A. Controlling Sickle Cell Disease: The need of the hour. Clinical Epidemiology and Global Health. 2023;21:101302. doi 10.1016/j.cegh.2023.101302. Impact Factor: 2.6
• Srivastava S, Kumar R. Is hyperleptinemia associated with gallstone disease? A systematic review and meta-analysis. Indian J Gastroenterol. 2023;42(3):324-331. doi: 10.1007/s12664-022-01332-6. Impact Factor: 2.00